Inforgraphic: Innovation in Pharma 2013

Written by on December 12, 2013 in Drug Discovery, Partnering & Investment with 4 Comments

Last week saw Deloitte publish it’s fourth annual report looking at the return on investment pharmaceutical companies are seeing in their research and development projects.

The report, co-produced with Thomson Reuters, looks at the current state of development pipelines in 12 top life science companies, and calculates a projected financial return for their products in the late stages of the pipeline.

To see what the report suggests will help to pull pharma out of this decline in value of  R&D investments why not have a read of our post on what pharma companies should take away from the report.

This infographic looks at just a few of the take-away statistics from the report:

measuring the resturn from pharmaceutical innovation 2013

See the original infographic here.

Tags: , , ,

About the Author

About the Author: Despite holding a degree in philosophy, I've a taste for the scientific and the experimental. With interests in innovation, experimentation and business strategy within the life sciences you will find me writing for Vaccine Nation, Total Orphan Drugs, and Total BioPharma .


If you enjoyed this article, subscribe now to receive more just like it.

4 Reader Comments

Trackback URL Comments RSS Feed

  1. lifescience says:

    This posting is marvelous and what a fantastic research that you have done. It has helped me a lot. thank you very much. Feel free to visit my buy portfolio lighting site.

    Sire Life Sciences

Leave a Reply

Your email address will not be published. Required fields are marked *

Current ye@r *